Methadone Opiates: UK Based Diagnostic Company, Randox, Expand Their Portfolio to Meet Demand for Forensic Drug Testing
As drug abuse and drug related crimes continue to prevail, expert forensic analysis is fundamental to the justice process. Global diagnostic company Randox Laboratories has released a number of new products for drug testing in public and private laboratories worldwide.
Local scientists and engineers at their UK headquarters design and manufacture products including traditional homogeneous methodology, pioneering Biochip Array Technology and Quality Management solutions. As the demand for forensic investigations is at an all time high, toxicologists are under pressure to produce case evidence without delay. Such evidence is vital to understanding events such as road accidents, poisoning and other causes of death. Testing of biological samples can be used to determine the presence of legal and illegal substances which may have been an influencing factor.
In 2010 Randox released a Drugs of Abuse array (DoA I+), adding to their considerable test menu of legal and illegal drugs. Tests available include; amphetamine, methamphetamine, barbituates, benzodiazepine 1 and 2, cannabinoids, cocaine metabolite, methadone, opiates and phencyclidine, buprenorphine, fentanyl, generic opioids, ketamine, LSD, MDMA, methaqualone, oxycodone 1 and 2, propoxyphene, MDMA, Buprenorphine and TCA. All tests are measured simultaneously from a single sample.
A number of drugs analytes are grouped and carried out on a biochip to allow for consolidated testing. Biochip Array Technology has been a ground-breaking development in the practice of forensic analysis, creating a reduction in the amount of time spent on individual tests. The multi-marker process allows toxicologists to determine a substantial amount of information from a small volume of sample, where sample is often limited. Most importantly the technology incorporating proven ELISA principles, provides accurate and reliable results which can be relied on in court.
Forensic evidence may be used in court, therefore it is crucial to have quality assured products and procedures in place. Randox manufacture antibodies onsite allowing them to sustain quality while continually expanding their test portfolio. Randox also offer drug testing solutions for clinical toxicology, workplace drug testing and onsite testing environments.
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of forensic toxicology, clinical chemistry, cardiology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. A continuous strategy of innovation has allowed Randox to revolutionise technology for the forensic toxicology market. Significant re-investment in Research and Development has seen the novel Biochip Array Technology adapt and evolve, with four analysers available for various settings. Twenty international offices and over one hundred distribution partners, ensure a high level of customer service worldwide.
Methadone Opiates: Jail’s methadone license lapses
VALHALLA — Federal investigators are looking into whether the health care provider at the Westchester County jail improperly dispensed methadone without a license over the past 10 months.
Read more on The Journal News
Methadone Opiates: Most overdose deaths in King County don’t involve illegal drugs
While prescription drugs or alcohol have largely eclipsed illegal drugs as the leading cause of overdose deaths in King County, illegal drugs such as cocaine still cause many fatal overdoses, according to a new University of Washington study.
Read more on Seattle Times
Related Methadone Opiates Information…